Latanoprost

ANDA 90887, held by Epic Pharma LLC. Latanoprost.

As of Nov 15, 2026, ANDA 90887 (Latanoprost), held by Epic Pharma LLC, was first approved by FDA on Jul 19, 2011, with 4 approved supplements and 0 published complete response letters.

First approved: Jul 19, 2011
Supplements approved: 4
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 5 submissions below

Date	Submission	Status	Documents
Jul 19, 2011	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Latanoprost0.005% · solution/drops;ophthalmic	Latanoprost	Discontinued

All 5 submissions, including labeling and manufacturing supplements


Jan 30, 2026	Supplement 15Labeling · Standard review	Approved	None posted
Jan 30, 2026	Supplement 16Labeling · Standard review	Approved	None posted
Jan 30, 2026	Supplement 17Labeling · Standard review	Approved	None posted
Sep 22, 2014	Supplement 9Manufacturing	Approved	None posted
Jul 19, 2011	Original application	Approved	None posted

Identifiers

Application: ANDA 90887
Drugs@FDA: Overview at FDA
Company: Epic Pharma

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters